Shanghai Cancer Center News

نویسنده

  • Richard Nakamura
چکیده

本报讯 4月 28日,在北京人民大会 堂,我国以最高规格表彰劳动模范,授予 2064人全国劳动模范荣誉称号、授予 904 人全国先进工作者荣誉称号。在这些人 当中,有 162人是来自于医疗战线的医务 工作者,其中 78名院长(含副院长、卫计 委主任、医学院院长),75名医生(含医院 质控和卫生防疫),以及 9 名护士,他们 当中有 44人为女性。统计显示,医务工 作者占被表彰劳动者总人数的 5.45%。 获得“全国先进工作者”称号的我院 乳腺外科主任邵志敏教授,始终站在攻 克乳腺癌临床及基础研究的第一线。临 床工作中,他致力于建立、优化和推广乳 腺癌多学科治疗模式及早期诊断模式。 身为乳腺外科主任及乳腺癌多学科综合 诊治团队首席专家,邵志敏教授带领的 团队 2014 年乳腺癌手术例数 3932 例, 门诊量 162159人次,诊疗病例数占全上 海乳腺癌病例近 43豫,同时单病种收费 低于上海平均水平,诊治的玉、域、芋期 乳腺癌患者术后五年生存率分别为 94%、84%和 64%,均达到国际先进水平。 自 2008 年科室牵头对上海七宝社区女 性进行乳腺普查,将乳癌检出率从对照 的 79/10万增至 262/10万,建立了适合 国人的社区筛查模式。 临床工作之余,他常常要求自己“不 能只做一名‘开刀匠’”。身为肿瘤研究所 所长的邵志敏教授,引进国内外优秀有 潜力的年轻 PI,并建立多个科研平台,进 一步提高基础科研转化能力,在乳腺癌 遗传易感、转移机制以及分子分型等领 域取得重要突破,并在国内外肿瘤专业 杂志上发表论文 400余篇,其中被《Nat Rev Cancer》、《Lancet Oncol》、《Nat Commun》、《Cancer Res》、《PloS Genet》 等 SCI 期刊收录 290余篇,平均影响因 子 4.5分,他引逾 4600次,其 H-index 为 37。作为中国抗癌协会乳腺癌专业委 员会名誉主任委员,邵志敏教授致力于 领导团结全国乳腺癌领域的工作者,在 其倡导带领下组建了 CBCSG(中国乳腺 癌研究协作组),开展了全国多中心临床 试验 10余项,其中多项研究已取得了瞩 目成绩,成果发表在《Lancet Oncology》 (IF24.7)等知名杂志上。 此外,他还兼任第八届亚洲乳腺癌 协会主席以及近两届 St.Gallen全球乳腺 癌大会专家团成员,在 SABCS等国际大 会的舞台上传播我国最新研究成果及治 疗理念,发出中国专家的权威声音。 繁忙的工作之余,他还热心于社会 公益活动,积极参加各种公益讲座、义诊 等,协助创办乳腺癌患者康复俱乐部妍 康沙龙,向全社会普及防治乳腺癌知识。 (宣传部综合报道)

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bjrd15726 1..7

1,2BIN WU, MD, 2,3TUANQI SUN, MD, 1,2YAJIA GU, MD, 1,2WEIJUN PENG, MD, 2,3ZHUOYING WANG, MD, 2,4RUI BI, MD and 2,3QINGHAI JI Department of Radiology, Fudan University Shanghai Cancer Center (FUSCC), Shanghai, China Department of Oncology, Shanghai Medical College, Fudan Univerisity, Shanghai, China Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center (FUSCC), Shanghai, C...

متن کامل

LYMPHOID NEOPLASIA Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma

1International Joint Cancer Institute and 301 General Hospital Cancer Center, Second Military Medical University, Shanghai; 2National Engineering Research Center for Antibody Medicine and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai; and 3School of Medicine and School of Pharmacy, Center for Antibody Medicine of Ministry of Education, Shanghai Jiao Tong University, Shanghai,...

متن کامل

A Cross-Cultural Pragmatic Study of Indirect Complaint Responses in Iranian and American News Interviews: Iran’s Nuclear Negotiations

The present study intended to compare the complaint responses used by President Rouhani and President Obama in the Iranian and US news interview contexts. For this purpose, Boxer’s (1993) six types of indirect complaint responses were adopted: ‘ignorance’, ‘questions’, ‘topic switch’, ‘contradiction’, ‘joke/teasing’, ‘advice/lecture’ and ‘agreement/commiseration’. The transcripts of the live ne...

متن کامل

High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients

Key Laboratory of Systems Biomedicine (Ministry of Education), School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai, 200030, China; NanoSystems Biology Cancer Center, California Institute of Technology, Pasadena, CA 91125; Division of Chemistry and Chemical Engineering, California Institute of Te...

متن کامل

A Cross-Cultural Pragmatic Study of Indirect Complaint Responses in Iranian and American News Interviews: Iran’s Nuclear Negotiations

The present study intended to compare the complaint responses used by President Rouhani and President Obama in the Iranian and US news interview contexts. For this purpose, Boxer’s (1993) six types of indirect complaint responses were adopted: ‘ignorance’, ‘questions’, ‘topic switch’, ‘contradiction’, ‘joke/teasing’, ‘advice/lecture’ and ‘agreement/commiseration’. The transcripts of the live ne...

متن کامل

IMMUNOBIOLOGY Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma Running head: ANTITUMOR ACTIVITY OF NEW RITUXIMAB VARIANTS

International Joint Cancer Institute and 301 General Hospital Cancer Center, Second Military Medical University, Shanghai 200433, People’s Republic of China; National Engineering Research Center for Antibody Medicine and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai 201203, People’s Republic of China School of Medicine and School of Pharmacy, The Center for Antibody Medicine ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015